In addition, the mRNA expression levels of BDKRB2 in the ROP+ACEi group (1.00-fold ± 0.15) were significantly higher than in the ROP-Ctrl group (0.56-fold ± 0.08) (P = 0.0453). This evidence concerns the gene BDKRB2 and retinopathy of prematurity.